Hanlon Investment Management’s Kinder Morgan KMI Stock Holding History

Hanlon Investment Management’s Portfolio KMI Stock Details KMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,046	Closed	-$236K	–	236
2026 Q1	$236K	Buy	+7,046	New	+$220K	0.13%	194
2016 Q3	–	Sell	-272,709	Closed	-$5.11M	–	77
2016 Q2	$5.11M	Buy	+272,709	New	+$4.86M	0.44%	30

Other funds holding KMI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Hanlon Investment Management's KMI Position: Q2 2026 in Review

Hanlon Investment Management sold out of Kinder Morgan (KMI) in Q2 2026, closing a stake of 7,046 shares — an estimated $236K sold.

Hanlon Investment Management first reported a position in KMI in Q2 2016 and held it in 2 quarters. The position peaked at $5.11M in Q2 2016. 1,824 funds tracked by Wall St. Rank hold KMI as of Q2 2026.

Hanlon Investment Management reported no remaining Kinder Morgan position as of Q2 2026 after selling out during the quarter.
Hanlon Investment Management sold 7,046 Kinder Morgan shares in Q2 2026, an estimated $236K.
Hanlon Investment Management first reported a position in Kinder Morgan in Q2 2016 and held it in 2 quarters.
Hanlon Investment Management's Kinder Morgan position peaked at $5.11M in Q2 2016.
1,824 funds tracked by Wall St. Rank held Kinder Morgan as of Q2 2026.

Based on Hanlon Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.